By clicking “Accept All Cookies” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Privacy PolicyMolecular Microbiology Software Market (By Type: Cloud Based, On-Premises; By Application: Pharmaceutical and Biotechnology, Academic and Research Centers, Hospital, Others; By Region: North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
The global molecular microbiology software market, valued at USD 94.27 million in 2024, is forecast to reach USD 188.94 million by 2034, advancing at a 7.2% CAGR amid growing adoption of digital lab solutions.
| Reports Attributes | Statistics |
| Market Size in 2024 | USD 94.27 Billion |
| Market Size in 2025 | USD 101.06 Billion |
| Market Size in 2031 | USD 153.37 Billion |
| Market Size by 2034 | USD 188.94 Billion |
| CAGR 2025 to 2034 | 7.2% |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Reports Attributes | Statistics |
| Market Size in 2024 | USD 609 Million |
| Market Size in 2025 | USD 651.63 Million |
| Market Size in 2031 | USD 1,046.38 Million |
| Market Size by 2034 | USD 1,198 Million |
| CAGR 2025 to 2034 | 7% |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Regions | Shares (%) |
| North America | 45% |
| Asia Pacific | 30% |
| Europe | 20% |
| LAMEA | 5% |
| Segments | Shares (%) |
| Cloud Based | 60% |
| On-Premises | 40% |
| Segments | Shares (%) |
| Pharmaceutical and Biotechnology | 40% |
| Academic and Research Centers | 30% |
| Hospital | 20% |
| Others | 10% |
Published by Yogesh Kulkarni
| Type_ | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cloud Based | 56.56 | 61.85 | 67.60 | 73.86 | 80.67 | 88.08 | 96.14 | 104.90 | 114.43 | 124.78 | 136.04 |
| On-Premises | 37.71 | 39.21 | 40.73 | 42.27 | 43.82 | 45.38 | 46.93 | 48.47 | 49.98 | 51.47 | 52.90 |
| Application_ | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical and Biotechnology | 37.71 | 40.93 | 44.42 | 48.20 | 52.29 | 56.72 | 61.52 | 66.72 | 72.34 | 78.43 | 85.02 |
| Academic and Research Centers | 28.28 | 29.81 | 31.42 | 33.10 | 34.86 | 36.70 | 38.63 | 40.64 | 42.75 | 44.94 | 47.24 |
| Hospital | 18.85 | 20.41 | 22.10 | 23.92 | 25.90 | 28.03 | 30.33 | 32.82 | 35.51 | 38.42 | 41.57 |
| Others | 9.43 | 9.90 | 10.40 | 10.92 | 11.45 | 12.01 | 12.59 | 13.19 | 13.81 | 14.45 | 15.12 |
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 42.42 | 44.97 | 47.67 | 50.52 | 53.53 | 56.72 | 60.09 | 63.65 | 67.41 | 71.38 | 75.58 |
| Asia Pacific | 28.28 | 31.13 | 34.23 | 37.63 | 41.33 | 45.38 | 49.79 | 54.60 | 59.85 | 65.57 | 71.80 |
| Europe | 18.85 | 20.01 | 21.23 | 22.53 | 23.90 | 25.36 | 26.90 | 28.53 | 30.25 | 32.08 | 34.01 |
| LAMEA | 4.71 | 4.95 | 5.20 | 5.46 | 5.73 | 6.01 | 6.30 | 6.60 | 6.91 | 7.23 | 7.56 |
| Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cloud Based | 56.56 | 61.85 | 67.60 | 73.86 | 80.67 | 88.08 | 96.14 | 104.90 | 114.43 | 124.78 | 136.04 |
| On-Premises | 37.71 | 39.21 | 40.73 | 42.27 | 43.82 | 45.38 | 46.93 | 48.47 | 49.98 | 51.47 | 52.90 |
| Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical and Biotechnology | 37.71 | 40.93 | 44.42 | 48.20 | 52.29 | 56.72 | 61.52 | 66.72 | 72.34 | 78.43 | 85.02 |
| Academic and Research Centers | 28.28 | 29.81 | 31.42 | 33.10 | 34.86 | 36.70 | 38.63 | 40.64 | 42.75 | 44.94 | 47.24 |
| Hospital | 18.85 | 20.41 | 22.10 | 23.92 | 25.90 | 28.03 | 30.33 | 32.82 | 35.51 | 38.42 | 41.57 |
| Others | 9.43 | 9.90 | 10.40 | 10.92 | 11.45 | 12.01 | 12.59 | 13.19 | 13.81 | 14.45 | 15.12 |
| Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 42.42 | 44.97 | 47.67 | 50.52 | 53.53 | 56.72 | 60.09 | 63.65 | 67.41 | 71.38 | 75.58 |
| Asia Pacific | 28.28 | 31.13 | 34.23 | 37.63 | 41.33 | 45.38 | 49.79 | 54.60 | 59.85 | 65.57 | 71.80 |
| Europe | 18.85 | 20.01 | 21.23 | 22.53 | 23.90 | 25.36 | 26.90 | 28.53 | 30.25 | 32.08 | 34.01 |
| LAMEA | 4.71 | 4.95 | 5.20 | 5.46 | 5.73 | 6.01 | 6.30 | 6.60 | 6.91 | 7.23 | 7.56 |
To get full access to our Market Insights, you need a Professional Account or a Business Suite.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Our customers work more efficiently and benefit from
